SlideShare a Scribd company logo
1 of 26
Antibiotic Stewardship and
Veterinary Medicine
Alternate Title
Regimen Rage from a
Clinical Pharmacologist
The carconnection.com
The Basics of Clinical Pharmacology
(in one slide)
•Can I do some good?
•Can I do any harm?
•Can I get it in the animal(s)?
•What is the cost?
Stewardship includes...
• Judicious use
• Treatment protocols
• Case definitions
• Regimen
• Drug
• Dose
• Route
• Duration
• Frequency
• Success/failure definitions
• Post-treatment intervals
• Post-mortems
• Treatment failures
• Treatment records
Stewardship includes...
• Judicious use
• Treatment protocols
• Case definitions
• Regimen
• Drug
• Dose
• Route
• Duration
• Frequency
• Success/failure definitions
• Post-treatment intervals
• Post-mortems
• Treatment failures
• Treatment records
Withdrawal time
Stewardship includes...
• Judicious use
• Treatment protocols
• Case definitions
• Regimen
• Drug
• Dose
• Route
•Duration
• Frequency
• Success/failure definitions
• Post-treatment intervals
• Post-mortems
• Treatment failures
• Treatment records
Withdrawal time
Stewardship includes...
• Judicious use
• Treatment protocols
• Case definitions
• Regimen
• Drug
• Dose
• Route
•Duration
• Frequency
• Success/failure definitions
• Post-treatment intervals
• Post-mortems
• Treatment failures
• Treatment records
Withdrawal time
But stewardship starts with…
• Prevention of infectious disease
• Have I taken every step possible to eliminate the need
for prevention, control, or therapy?
• Is it really needed?
• Is there a disease present or imminent which requires
an antibiotic for prevention, control, or therapy?
• Is this a disease that will respond to antibiotics?
But stewardship starts with…
• Does the antibiotic I am considering have a
chance?
• Spectrum
• System and industry-wide monitoring of antibiotic
susceptibility for key pathogens
• This assumes we have breakpoints which apply to the
pathogen/disease/animal/regimen in question…
• Are other’s doing the same thing? More? Less?
• Metrics
Speaking of metrics
• In my opinion, antimicrobial use monitoring
should be actual use, tied to reason for use
• Total kg as a metric only serves as a stick to drive “cut
the use” as a goal
• Animal Daily Doses (ADD) and Animal Regimens (AR)
provide a look into drug exposure as well as number of
animals receiving the regimen.
• There may be different regimens for the same drug in a
species.
Antimicrobial Use Monitoring
• Sales data do not drive accurate estimates of
indications for use, or even actual use
Antimicrobial Use Monitoring
• The only way to drive the needed granularity in
the data is to …
• Give agriculture the steering wheel for data collection
• Government audit of the sampling strategy and data
handling
• Absolute guarantee of anonymity for participants
• Sampling structure must balance a view of the industry
with utility for individual participants
Fundamentals
• Denominators really, really matter
• Numerators are relatively easy
• And this has driven an interactive environment for this
issue in which some engage based only on numerators
Antimicrobial Use Monitoring
• Only actual use tied to reason for use will allow us
to drive antimicrobial stewardship in food animals
• Participants must be able to anonymously compare
themselves to peers in a private venue, and…
• investigate reasons for differences from peers
Is it as simple as…
•Label use?
• See previous slides
• Could I have avoided the disease challenge?
• Is an antibiotic actually needed?
• is the disease challenge actually present or
imminent?
• Is there a chance for efficacy?
• And, label use has nothing to do with
magnitude of selection for resistance
Labeled use doesn’t necessarily
mean…
• Judicious use, or
• Compatible with stewardship, or
• The regimen most likely to minimize selection for
resistant organisms
Is it as simple as…
• 100 mg in one animal = one resistance factory….
1 mg in each of 100 animals = 100 resistance
factories
• Who decided that the exposure dynamics for growth
promotion (low and long) are the most likely to select
for resistant organisms?
• Don’t confuse a policy decision to reduce total kg of
drug with proof that this exposure is the worst
exposure to select for resistant organisms
Time to wake up…
• The PK/PD parameters for efficacy don’t
necessarily match with optimal exposure for
minimizing the selection for resistant organisms.
• Maybe the marketing guys aren’t the ones who
understand what the best PK exposure is?
• We have focused on dose comparisons for the
same duration in veterinary and human medicine
• Take your antibiotic for as long as your doctor
prescribes so that you don’t get a relapse with a
resistant infection
Time to wake up…
•Narrow spectrum…what is “narrow
spectrum”
• Does a definition based on therapeutic effect
apply to avoiding selection for resistant
organisms?
What is “Stewardship”?
Is there a non-antibiotic alternative
which will appropriately prevent,
control, or treat this disease challenge?
Selection of an antibiotic which
has been demonstrated to be safe
and effective for this purpose
Assuring use of the
antibiotic as shown to
be safe and effective
While…
Education without systems
change will not work
 Unthinkable
 Radical
 Acceptable
 Sensible
 Popular
 Policy Prohibition of growth
promotion uses of medically
important antimicrobials
Prohibition of prevention
and control uses of medically
important antimicrobials
Prohibition of therapeutic
uses of medically important
antimicrobials
Rushworth Kidder told us…
• Right vs. wrong is easy, it’s right vs. right that is
hard
• He outlines 4 basic components of ethical
dilemmas
• Short term vs. Long Term
• Individual vs. Community
• Truth vs. Loyalty
• Justice vs. Mercy
This is Stewardship
The veterinary profession is
not only going to be
responsible for all medically-
important antimicrobial uses in
food animals…
we are going to be
accountable
…from here
• The days of verbal treatment protocols are
gone
• The days of unacceptable treatment records
are gone
• The days of nontransparent use of
antimicrobials in food animals are coming
to an end
• Neither veterinarians or producers can be
passive in these efforts.

More Related Content

What's hot

Pharmacy practice high impact article m.luisetto 2016 research and reviews
Pharmacy practice  high impact article m.luisetto 2016 research and reviewsPharmacy practice  high impact article m.luisetto 2016 research and reviews
Pharmacy practice high impact article m.luisetto 2016 research and reviews
M. Luisetto Pharm.D.Spec. Pharmacology
 
Hospital at Home poster- final
Hospital at Home poster- finalHospital at Home poster- final
Hospital at Home poster- final
Maria Veart
 
Successful New Drug Development Strategies for Small Companies
Successful New Drug Development Strategies for Small CompaniesSuccessful New Drug Development Strategies for Small Companies
Successful New Drug Development Strategies for Small Companies
francjohn
 
Superiority, non-inferiority, equivalence studies - what is the difference?
Superiority, non-inferiority, equivalence studies - what is the difference?Superiority, non-inferiority, equivalence studies - what is the difference?
Superiority, non-inferiority, equivalence studies - what is the difference?
simonledinek
 

What's hot (19)

Anesthesiology Orientation Aug 2009
Anesthesiology Orientation Aug 2009Anesthesiology Orientation Aug 2009
Anesthesiology Orientation Aug 2009
 
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
MDC Connects Series 2021 | A Guide to Complex Medicines: What is the commerci...
 
Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124Clinical Trial Simulation training with simulo 20161124
Clinical Trial Simulation training with simulo 20161124
 
Pharmacist
PharmacistPharmacist
Pharmacist
 
Pharmacy practice high impact article m.luisetto 2016 research and reviews
Pharmacy practice  high impact article m.luisetto 2016 research and reviewsPharmacy practice  high impact article m.luisetto 2016 research and reviews
Pharmacy practice high impact article m.luisetto 2016 research and reviews
 
Hospital at Home poster- final
Hospital at Home poster- finalHospital at Home poster- final
Hospital at Home poster- final
 
EOP.SOJA.S5
EOP.SOJA.S5EOP.SOJA.S5
EOP.SOJA.S5
 
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
Superiority Trials Versus Non-Inferiority Trials to Demonstrate Effectiveness...
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for O...
 
Ther worksheet
Ther worksheetTher worksheet
Ther worksheet
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
 
Successful New Drug Development Strategies for Small Companies
Successful New Drug Development Strategies for Small CompaniesSuccessful New Drug Development Strategies for Small Companies
Successful New Drug Development Strategies for Small Companies
 
Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Best way for sales reps to gain access to physicians
Best way for sales reps to gain access to physiciansBest way for sales reps to gain access to physicians
Best way for sales reps to gain access to physicians
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
CLINICAL DATA MANAGEMENT SAS CDM Online Learning
CLINICAL DATA MANAGEMENT SAS CDM Online LearningCLINICAL DATA MANAGEMENT SAS CDM Online Learning
CLINICAL DATA MANAGEMENT SAS CDM Online Learning
 
Superiority, non-inferiority, equivalence studies - what is the difference?
Superiority, non-inferiority, equivalence studies - what is the difference?Superiority, non-inferiority, equivalence studies - what is the difference?
Superiority, non-inferiority, equivalence studies - what is the difference?
 

Viewers also liked (6)

TruCare Pharmacy Veterinary Tips: Frightened Dogs
TruCare Pharmacy Veterinary Tips: Frightened DogsTruCare Pharmacy Veterinary Tips: Frightened Dogs
TruCare Pharmacy Veterinary Tips: Frightened Dogs
 
Antibiotic resistance -aveen omer
Antibiotic resistance -aveen omerAntibiotic resistance -aveen omer
Antibiotic resistance -aveen omer
 
Antibiotics in ophthalmology
Antibiotics in ophthalmologyAntibiotics in ophthalmology
Antibiotics in ophthalmology
 
Veterinary pharmacy
Veterinary pharmacyVeterinary pharmacy
Veterinary pharmacy
 
215 antibio
215 antibio215 antibio
215 antibio
 
Antibiotic principles
Antibiotic principlesAntibiotic principles
Antibiotic principles
 

Similar to Dr. Mike Apley - Antibiotic Stewardship and Animal Agriculture

Clinical trials: exploring your options - Deirdre McDonnell
Clinical trials: exploring your options - Deirdre McDonnellClinical trials: exploring your options - Deirdre McDonnell
Clinical trials: exploring your options - Deirdre McDonnell
Irish Cancer Society
 

Similar to Dr. Mike Apley - Antibiotic Stewardship and Animal Agriculture (20)

Dr. Larry Granger - USDA Antimicrobial Resistance Strategy - Farm Foundation ...
Dr. Larry Granger - USDA Antimicrobial Resistance Strategy - Farm Foundation ...Dr. Larry Granger - USDA Antimicrobial Resistance Strategy - Farm Foundation ...
Dr. Larry Granger - USDA Antimicrobial Resistance Strategy - Farm Foundation ...
 
Clinical trials: exploring your options - Deirdre McDonnell
Clinical trials: exploring your options - Deirdre McDonnellClinical trials: exploring your options - Deirdre McDonnell
Clinical trials: exploring your options - Deirdre McDonnell
 
Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...
Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...
Dr. Mike Apley - Antibiotics in the Future Tense: How the Last 5 Years Have S...
 
An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry An overview of the Pharmaceutical Industry
An overview of the Pharmaceutical Industry
 
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health PerspectiveDr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
Dr. Michael D. Apley - Antibiotic Resistance: A One Health Perspective
 
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
Dr. Mike Apley - Where Are We With Resistance in Vet Medicine? Are We Having ...
 
Dr. Jeff Bender - Companion Animal Antimicrobial Stewardship
Dr. Jeff Bender - Companion Animal Antimicrobial StewardshipDr. Jeff Bender - Companion Animal Antimicrobial Stewardship
Dr. Jeff Bender - Companion Animal Antimicrobial Stewardship
 
Medication safety; today and tomorrow
Medication safety; today and tomorrowMedication safety; today and tomorrow
Medication safety; today and tomorrow
 
medication safety
medication safetymedication safety
medication safety
 
Applying HealthNewsReview.org criteria
Applying HealthNewsReview.org criteria Applying HealthNewsReview.org criteria
Applying HealthNewsReview.org criteria
 
Medical Reversals. Why 40% of What We Do Is Wrong
Medical Reversals. Why 40% of What We Do Is WrongMedical Reversals. Why 40% of What We Do Is Wrong
Medical Reversals. Why 40% of What We Do Is Wrong
 
Clinical Trials and Cooperative Group Studies - WIMR @FightCRC @CRCRes16
Clinical Trials and Cooperative Group Studies - WIMR @FightCRC @CRCRes16Clinical Trials and Cooperative Group Studies - WIMR @FightCRC @CRCRes16
Clinical Trials and Cooperative Group Studies - WIMR @FightCRC @CRCRes16
 
Strategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medicationStrategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medication
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Experimental epidemiological studies
Experimental epidemiological studiesExperimental epidemiological studies
Experimental epidemiological studies
 
Clinical Research in CAM: Requirements, Complexities and Possibilities
Clinical Research in CAM: Requirements,  Complexities and PossibilitiesClinical Research in CAM: Requirements,  Complexities and Possibilities
Clinical Research in CAM: Requirements, Complexities and Possibilities
 
Clinical Trials - Why We Need Them?
Clinical Trials - Why We Need Them?Clinical Trials - Why We Need Them?
Clinical Trials - Why We Need Them?
 
Safe & Effective Management of Chronic Pain
Safe & Effective Management of Chronic Pain Safe & Effective Management of Chronic Pain
Safe & Effective Management of Chronic Pain
 
Safe & Effective Management of Chronic Pain
Safe & Effective Management of Chronic PainSafe & Effective Management of Chronic Pain
Safe & Effective Management of Chronic Pain
 
1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx
 

More from John Blue

More from John Blue (20)

Jordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification ProgramJordan Hoewischer - OACI Farmer Certification Program
Jordan Hoewischer - OACI Farmer Certification Program
 
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and IgnoranceFred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
Fred Yoder - No-till and Climate Change: Fact, Fiction, and Ignorance
 
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In KentuckyDr. John Grove - Fifty Years Of No-till Research In Kentucky
Dr. John Grove - Fifty Years Of No-till Research In Kentucky
 
Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962Dr. Warren Dick - Pioneering No-till Research Since 1962
Dr. Warren Dick - Pioneering No-till Research Since 1962
 
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...Dr. Christine Sprunger - The role that roots play in building soil organic ma...
Dr. Christine Sprunger - The role that roots play in building soil organic ma...
 
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
Dr. Leonardo Deiss - Stratification, the Role of Roots, and Yield Trends afte...
 
Dr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data AnalysisDr. Steve Culman - No-Till Yield Data Analysis
Dr. Steve Culman - No-Till Yield Data Analysis
 
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
Alan Sundermeier and Dr. Vinayak Shedekar - Soil biological Response to BMPs
 
Dr. Curtis Young - Attracting And Protecting Pollinators
 Dr. Curtis Young - Attracting And Protecting Pollinators Dr. Curtis Young - Attracting And Protecting Pollinators
Dr. Curtis Young - Attracting And Protecting Pollinators
 
Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages Garth Ruff - Alternative Forages
Garth Ruff - Alternative Forages
 
Sarah Noggle - Cover Crop Decision Tool Selector
 Sarah Noggle - Cover Crop Decision Tool Selector Sarah Noggle - Cover Crop Decision Tool Selector
Sarah Noggle - Cover Crop Decision Tool Selector
 
Jim Belt - Hemp Regulations
Jim Belt - Hemp RegulationsJim Belt - Hemp Regulations
Jim Belt - Hemp Regulations
 
John Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's NextJohn Barker - UAVs: Where Are We And What's Next
John Barker - UAVs: Where Are We And What's Next
 
Dr. Rajbir Bajwa - Medical uses of Marijuana
 Dr. Rajbir Bajwa - Medical uses of Marijuana Dr. Rajbir Bajwa - Medical uses of Marijuana
Dr. Rajbir Bajwa - Medical uses of Marijuana
 
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
Dr. Jeff Stachler - Setting up a Corn and Soybean Herbicide Program with Cove...
 
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
Dr. Chad Penn - Developing A New Approach To Soil Phosphorus Testing And Reco...
 
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative PlantingJim Hoorman - Dealing with Cover Crops after Preventative Planting
Jim Hoorman - Dealing with Cover Crops after Preventative Planting
 
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
Dr. Sjoerd Duiker - Dealing with Poor Soil Structure and Soil Compaction
 
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water QualityChristine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
Christine Brown - Canadian Livestock Producers Efforts to Improve Water Quality
 
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
Dr. Lee Briese - Details Matter (includes details about soil, equipment, cove...
 

Recently uploaded

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 

Dr. Mike Apley - Antibiotic Stewardship and Animal Agriculture

  • 2. Alternate Title Regimen Rage from a Clinical Pharmacologist The carconnection.com
  • 3. The Basics of Clinical Pharmacology (in one slide) •Can I do some good? •Can I do any harm? •Can I get it in the animal(s)? •What is the cost?
  • 4. Stewardship includes... • Judicious use • Treatment protocols • Case definitions • Regimen • Drug • Dose • Route • Duration • Frequency • Success/failure definitions • Post-treatment intervals • Post-mortems • Treatment failures • Treatment records
  • 5. Stewardship includes... • Judicious use • Treatment protocols • Case definitions • Regimen • Drug • Dose • Route • Duration • Frequency • Success/failure definitions • Post-treatment intervals • Post-mortems • Treatment failures • Treatment records Withdrawal time
  • 6. Stewardship includes... • Judicious use • Treatment protocols • Case definitions • Regimen • Drug • Dose • Route •Duration • Frequency • Success/failure definitions • Post-treatment intervals • Post-mortems • Treatment failures • Treatment records Withdrawal time
  • 7. Stewardship includes... • Judicious use • Treatment protocols • Case definitions • Regimen • Drug • Dose • Route •Duration • Frequency • Success/failure definitions • Post-treatment intervals • Post-mortems • Treatment failures • Treatment records Withdrawal time
  • 8. But stewardship starts with… • Prevention of infectious disease • Have I taken every step possible to eliminate the need for prevention, control, or therapy? • Is it really needed? • Is there a disease present or imminent which requires an antibiotic for prevention, control, or therapy? • Is this a disease that will respond to antibiotics?
  • 9. But stewardship starts with… • Does the antibiotic I am considering have a chance? • Spectrum • System and industry-wide monitoring of antibiotic susceptibility for key pathogens • This assumes we have breakpoints which apply to the pathogen/disease/animal/regimen in question… • Are other’s doing the same thing? More? Less? • Metrics
  • 10. Speaking of metrics • In my opinion, antimicrobial use monitoring should be actual use, tied to reason for use • Total kg as a metric only serves as a stick to drive “cut the use” as a goal • Animal Daily Doses (ADD) and Animal Regimens (AR) provide a look into drug exposure as well as number of animals receiving the regimen. • There may be different regimens for the same drug in a species.
  • 11. Antimicrobial Use Monitoring • Sales data do not drive accurate estimates of indications for use, or even actual use
  • 12. Antimicrobial Use Monitoring • The only way to drive the needed granularity in the data is to … • Give agriculture the steering wheel for data collection • Government audit of the sampling strategy and data handling • Absolute guarantee of anonymity for participants • Sampling structure must balance a view of the industry with utility for individual participants
  • 13. Fundamentals • Denominators really, really matter • Numerators are relatively easy • And this has driven an interactive environment for this issue in which some engage based only on numerators
  • 14. Antimicrobial Use Monitoring • Only actual use tied to reason for use will allow us to drive antimicrobial stewardship in food animals • Participants must be able to anonymously compare themselves to peers in a private venue, and… • investigate reasons for differences from peers
  • 15. Is it as simple as… •Label use? • See previous slides • Could I have avoided the disease challenge? • Is an antibiotic actually needed? • is the disease challenge actually present or imminent? • Is there a chance for efficacy? • And, label use has nothing to do with magnitude of selection for resistance
  • 16. Labeled use doesn’t necessarily mean… • Judicious use, or • Compatible with stewardship, or • The regimen most likely to minimize selection for resistant organisms
  • 17. Is it as simple as… • 100 mg in one animal = one resistance factory…. 1 mg in each of 100 animals = 100 resistance factories • Who decided that the exposure dynamics for growth promotion (low and long) are the most likely to select for resistant organisms? • Don’t confuse a policy decision to reduce total kg of drug with proof that this exposure is the worst exposure to select for resistant organisms
  • 18. Time to wake up… • The PK/PD parameters for efficacy don’t necessarily match with optimal exposure for minimizing the selection for resistant organisms. • Maybe the marketing guys aren’t the ones who understand what the best PK exposure is? • We have focused on dose comparisons for the same duration in veterinary and human medicine • Take your antibiotic for as long as your doctor prescribes so that you don’t get a relapse with a resistant infection
  • 19. Time to wake up… •Narrow spectrum…what is “narrow spectrum” • Does a definition based on therapeutic effect apply to avoiding selection for resistant organisms?
  • 20. What is “Stewardship”? Is there a non-antibiotic alternative which will appropriately prevent, control, or treat this disease challenge? Selection of an antibiotic which has been demonstrated to be safe and effective for this purpose Assuring use of the antibiotic as shown to be safe and effective While…
  • 22.
  • 23.  Unthinkable  Radical  Acceptable  Sensible  Popular  Policy Prohibition of growth promotion uses of medically important antimicrobials Prohibition of prevention and control uses of medically important antimicrobials Prohibition of therapeutic uses of medically important antimicrobials
  • 24. Rushworth Kidder told us… • Right vs. wrong is easy, it’s right vs. right that is hard • He outlines 4 basic components of ethical dilemmas • Short term vs. Long Term • Individual vs. Community • Truth vs. Loyalty • Justice vs. Mercy This is Stewardship
  • 25. The veterinary profession is not only going to be responsible for all medically- important antimicrobial uses in food animals… we are going to be accountable
  • 26. …from here • The days of verbal treatment protocols are gone • The days of unacceptable treatment records are gone • The days of nontransparent use of antimicrobials in food animals are coming to an end • Neither veterinarians or producers can be passive in these efforts.